Literature DB >> 15110112

Determining the safety of chromium tripicolinate for addition to foods as a nutrient supplement.

T O Berner1, M M Murphy, R Slesinski.   

Abstract

Trivalent chromium is an essential element required for normal carbohydrate, lipid, and protein metabolism in humans and animals. This article describes how one particular form of trivalent chromium, chromium tripicolinate (Chromax), a stable complex of trivalent chromium and picolinic acid, was determined to be safe for use as a nutrient supplement in foods (i.e., nutritional bars and beverages). A safety assessment of a nutrient supplement for use in food requires an evaluation of the safety of the product (Chromax), as well as an evaluation of the safety of the intended dietary ingredient (chromium tripicolinate). In this assessment, the production process, final product specifications, and product analysis results for Chromax were evaluated to determine the safety of the final product. Then, the Estimated Daily Intakes (EDIs) of trivalent chromium and picolinic acid from the proposed use of Chromax were calculated using data from the USDA's most recent Continuing Survey of Food Intakes by Individuals. The EDI for trivalent chromium was compared to the Acceptable Daily Intake (ADI) for this compound derived from animal studies, corroborated with human data, while the EDI for picolinic acid was compared to existing in vivo exposure to this compound that occurs naturally in the body. As long as the EDI of trivalent chromium is less than the ADI for this compound and the EDI of picolinic acid is less than its estimated in vivo exposure, Chromax can be considered safe for its intended use. Employing this approach, it was determined that Chromax is safe, as well as generally recognized as safe (GRAS), for use in nutritional bars and beverages as a nutrient supplement at a maximum use level of 2.4 mg of Chromax per product serving.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15110112     DOI: 10.1016/j.fct.2004.02.015

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  3 in total

Review 1.  Chromium Supplementation; Negotiation with Diabetes Mellitus, Hyperlipidemia and Depression.

Authors:  Amir Khodavirdipour; Fatemeh Haddadi; Shiva Keshavarzi
Journal:  J Diabetes Metab Disord       Date:  2020-03-05

2.  Speciation of chromium in chromium yeast.

Authors:  Xuena Guo; Wei Liu; Xuejing Bai; Xiuping He; Borun Zhang
Journal:  World J Microbiol Biotechnol       Date:  2014-10-01       Impact factor: 3.312

3.  Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements.

Authors:  David J McIver; Ana Maria Grizales; John S Brownstein; Allison B Goldfine
Journal:  J Nutr       Date:  2015-10-07       Impact factor: 4.798

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.